Language selection

Search

Biomanufacturing: Projects underway


Current biomanufacturing projects across Canada

Timeline of biomanufacturing investments

  • 2021
  • February 2021

    Precision NanoSystems Inc.

    Precision NanoSystems Inc. (PNI) (Vancouver, British Columbia)

    A $25.1 million investment, through SIF, to support a $50.2-million project to expand capabilities in the production of ribonucleic acid (RNA) vaccines and future genetic medicines, while enhancing Canada's biomanufacturing capacity (February 2, 2021)

    Related link

  • January 2021

    Providence Therapeutics, in partnership with Northern RNA

    Providence Therapeutics, in partnership with Northern RNA (Calgary, Alberta)

    An investment of up to $5 million in Providence Therapeutics and Northern RNA Inc. through Next Generation Manufacturing Canada, Canada's advanced manufacturing supercluster, to expand their operations in Calgary to design and manufacture COVID-19 vaccines and build a pipeline of mRNA vaccines (January 21, 2021)

  • October 2020

    Medicago

    Medicago (Québec, Quebec)

    An investment of up to $173 million, through SIF, to advance its virus-like particle vaccine candidate and establish a large-scale biomanufacturing facility (October 23, 2020)

    Related link

  • May 2020

    AbCellera

    AbCellera (Vancouver, British Columbia)

    A $175.6-million investment through the Strategic Innovation Fund (SIF) toward antibody therapy research and the construction of an antibody production facility (May 3, 2020)

    Related link

  • March 2020

    NRC Royalmount

    Clinical trial material facility (Montréal, Quebec)

    A $44-million investment to establish a Good Manufacturing Practices (GMP) compliant facility for clinical trial materials at the National Research Council of Canada's (NRC) Royalmount site in Montréal. (March 23, 2020 and April 23, 2020)

    Biologics Manufacturing Centre (Montréal, Quebec)

    A $126-million investment to build a new Biologics Manufacturing Centre at the NRC's Royalmount site in Montréal for large-quantity, end-to-end production of vaccines. (August 31, 2020)

    Related link

    Vaccine and Infectious Disease Organization

    Vaccine and Infectious Disease Organization: International Vaccine Centre (VIDO-InterVac), (Saskatoon, Saskatchewan)

    A $35-million investment through Western Economic Diversification Canada to accelerate development of its COVID-19 vaccine candidate and enhance its vaccine manufacturing

    Related link

  • 2016

Planning for the future

In addition to biomanufacturing capacity, our investments will ensure that, in the long term, Canada has the talent, a research and development pipeline, robust SMEs and security across the supply chain to support a dynamic and growing biologics manufacturing and innovation ecosystem.

Work is under way to assess current and ongoing needs in the biomanufacturing sector and to find ways to complement recent government investments—such as those made through the Strategic Innovation Fund (SIF) and the National Research Council of Canada's Industrial Research Assistance Program (NRC IRAP).

Complete list of Government of Canada investments in COVID-19 vaccines and biomanufacturing capacity:

Date modified: